121 related articles for article (PubMed ID: 26063876)
1. Primary Systemic Treatment in the Management of Operable Breast Cancer: Best Surgical Approach for Diagnosis, Biological Evaluation, and Research.
Barry PA; Schiavon G
J Natl Cancer Inst Monogr; 2015 May; 2015(51):4-8. PubMed ID: 26063876
[TBL] [Abstract][Full Text] [Related]
2. [Guideline 'Treatment of breast cancer 2008' (revision)].
Struikmans H; Nortier JW; Rutgers EJ; Zonderland HM; Bontenbal M; Elkhuizen PH; van Tienhoven G; Tjan-Heijnen VC; van Vegchel T; Tuut MK; Benraadt J
Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2507-11. PubMed ID: 19055257
[TBL] [Abstract][Full Text] [Related]
3. Optimizing Radiation Treatment Decisions for Patients Who Receive Neoadjuvant Chemotherapy.
Magrini SM; Buglione M; Costa L
J Natl Cancer Inst Monogr; 2015 May; 2015(51):9-10. PubMed ID: 26063877
[TBL] [Abstract][Full Text] [Related]
4. Current and future role of neoadjuvant therapy for breast cancer.
Untch M; Konecny GE; Paepke S; von Minckwitz G
Breast; 2014 Oct; 23(5):526-37. PubMed ID: 25034931
[TBL] [Abstract][Full Text] [Related]
5. Current and future roles of neoadjuvant chemotherapy in operable breast cancer.
Kim R; Osaki A; Toge T
Clin Breast Cancer; 2005 Aug; 6(3):223-32; discussion 233-4. PubMed ID: 16137432
[TBL] [Abstract][Full Text] [Related]
6. [Neoadjuvant treatment of breast cancer: implications for the pathologist].
Le Guellec S; Perallon R; Alunni JP; Charitansky H; Leaha C; Gonzalez AM; Chateau MC; Simony-Lafontaine J; Jacot W; Gutowski M; Penault-Llorca F; Dalenc F; Lacroix-Triki M
Ann Pathol; 2011 Dec; 31(6):442-54. PubMed ID: 22172117
[TBL] [Abstract][Full Text] [Related]
7. The role of the breast cancer surgeon in personalized cancer care: clinical utility of the 21-gene assay.
Laronga C; Harness JK; Dixon M; Borgen PI
Am J Surg; 2012 Jun; 203(6):751-8. PubMed ID: 22516676
[TBL] [Abstract][Full Text] [Related]
8. HER2-positive early breast cancer and trastuzumab: a surgeon's perspective.
Kulkarni S; Hicks DG
Ann Surg Oncol; 2008 Jun; 15(6):1677-88. PubMed ID: 18398661
[TBL] [Abstract][Full Text] [Related]
9. The surgeon's role in breast brachytherapy.
Beitsch PD; Hodge CW; Dowlat K; Francescatti D; Gittleman MA; Israel P; Nelson JC; Potruch T; Snider HC; Whitworth P; Zannis VJ; Patel RR
Breast J; 2009; 15(1):93-100. PubMed ID: 19141135
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant Treatment Approach: The Rosetta Stone for Breast Cancer?
Generali D; Ardine M; Strina C; Milani M; Cappelletti MR; Zanotti L; Forti M; Bedussi F; Martinotti M; Amoroso V; Sigala S; Simoncini E; Berruti A; Bottini A
J Natl Cancer Inst Monogr; 2015 May; 2015(51):32-5. PubMed ID: 26063883
[TBL] [Abstract][Full Text] [Related]
11. [Neoadjuvant systemic therapy in patients with operable primary breast cancer: more benefits than breast-conserving therapy].
Straver ME; van Adrichem JC; Rutgers EJ; Rodenhuis S; Linn SC; Loo CE; Gilhuijs KG; Oldenburg HS; Wesseling J; Russell NS; Antonini N; Vrancken Peeters MT
Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2519-25. PubMed ID: 19055260
[TBL] [Abstract][Full Text] [Related]
12. Management of locally advanced breast cancer. Mini-review.
Franceschini G; Terribile D; Fabbri C; Magno S; D'Alba P; Chiesa F; Di Leone A; Masetti R
Minerva Chir; 2007 Aug; 62(4):249-55. PubMed ID: 17641585
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy for early breast cancer.
Mieog JS; van de Velde CJ
Expert Opin Pharmacother; 2009 Jun; 10(9):1423-34. PubMed ID: 19505212
[TBL] [Abstract][Full Text] [Related]
14. Neoadjuvant chemotherapy for locally advanced breast cancer.
Specht J; Gralow JR
Semin Radiat Oncol; 2009 Oct; 19(4):222-8. PubMed ID: 19732686
[TBL] [Abstract][Full Text] [Related]
15. Clinical Diagnosis and Management of Breast Cancer.
McDonald ES; Clark AS; Tchou J; Zhang P; Freedman GM
J Nucl Med; 2016 Feb; 57 Suppl 1():9S-16S. PubMed ID: 26834110
[TBL] [Abstract][Full Text] [Related]
16. Neoadjuvant Chemotherapy: What Are the Benefits for the Patient and for the Investigator?
Hayes DF; Schott AF
J Natl Cancer Inst Monogr; 2015 May; 2015(51):36-9. PubMed ID: 26063884
[TBL] [Abstract][Full Text] [Related]
17. Neoadjuvant endocrine therapy and window of opportunity trials: new standards in the treatment of breast cancer?
Levasseur N; Clemons M; Hilton J; Addison C; Robertson S; Ibrahim M; Arnaout A
Minerva Chir; 2015 Jun; 70(3):181-93. PubMed ID: 25737461
[TBL] [Abstract][Full Text] [Related]
18. Surgery following neoadjuvant therapy in patients with HER2-positive locally advanced or inflammatory breast cancer participating in the NeOAdjuvant Herceptin (NOAH) study.
Semiglazov V; Eiermann W; Zambetti M; Manikhas A; Bozhok A; Lluch A; Tjulandin S; Sabadell MD; Caballero A; Valagussa P; Baselga J; Gianni L
Eur J Surg Oncol; 2011 Oct; 37(10):856-63. PubMed ID: 21843921
[TBL] [Abstract][Full Text] [Related]
19. Regarding: Valero V, Buzdar AU, Hortobagyi GN. "Locally Advanced Breast Cancer," The Oncologist 1996;1:8-17.
Oliver RT
Oncologist; 1996; 1(4):278-279. PubMed ID: 10388003
[TBL] [Abstract][Full Text] [Related]
20. The surgeon's role in molecular biology.
Rocco G
J Thorac Cardiovasc Surg; 2012 Sep; 144(3):S18-22. PubMed ID: 22739075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
